LAST PRICE - AT THE CLOSE
DRUG is DOWN -22% since the begininning of the year
DRUG is DOWN -18% BELOW 20 day SMA
DRUG is DOWN -17% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.793275
EARNINGS MOMENTUM: YES
0.38% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 51.0% AWAY FROM ALL-TIME HIGHS OF $123.75 |
 |
DRUG IS DOWN -22% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 115% OVER THE PAST 12 MONTHS |
 |
DRUG IS DOWN -19% OVER THE PAST 1 MONTH |
 |
11% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 0 over the last hour |
 |
DRUG is up 2.3% over the last 5 days |
 |
DRUG is 1.7 above its 8 day SMA |
| $59.00 |  DAY |
$62.55 |
| $58.10 | PREVIOUS DAY |
$61.82 |
| $56.47 |  WEEK |
$63.34 |
| $56.47 |  MONTH |
$92.00 |
| $23.18 | YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
